Brief: Cannara Biotech Inc Reports Preliminary Results Ahead Of Q3
28/06/2021 13:51
June 28 (Reuters) - Cannara Biotech Inc LOVE.V :
* CANNARA BIOTECH INC - EXPECTS TOTAL REVENUE, NET OF EXCISE
TAX,
FOR Q3 ENDED MAY 2021 TO BE APPROXIMATELY $7.1 MILLION
* CANNARA BIOTECH - CANNABIS REVENUE FROM PRODUCTS DESTINED
FOR
RETAIL IS EXPECTED TO BE IN RANGE OF $3.2 TO $3.4 MILLION FOR
QUARTER
Source text for Eikon: ID:nCNWyqz5da
Further company coverage: LOVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cannara Biotech
See all newsCanada Research Roundup: Cannara Biotech ,Equinox Gold , Winpak
Brief: Cannara Announces Strategic C$6.3 Million Non-Brokered Private Placement Priced At C$2.10 Per Common Share
Brief: Cannara Biotech Delivers Q4
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Brief: Cannara Biotech Q4 EPS CAD 0.04